Wu RH - Search Results

1

Pharmacokinetic Studies of Factor VIII in Chinese Boys with Severe Hemophilia A: A Single-Center Study.

Chen ZP, Li PJ, Li G, Tang L, Zhen YZ, Wu XY, Cheng XL, Luke KH, Blanchette VS, Poon MC, Ding QL, Wu RH. Chen ZP, et al. Among authors: wu xy, wu rh. Chin Med J (Engl). 2018 Aug 5;131(15):1780-1785. doi: 10.4103/0366-6999.233604. Chin Med J (Engl). 2018. PMID: 29848837 Free PMC article.

2

Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases.

Lu G, Xie ZD, Zhao SY, Ye LJ, Wu RH, Liu CY, Yang S, Jin YK, Shen KL. Lu G, et al. Among authors: wu rh. Chin Med J (Engl). 2009 Feb 5;122(3):262-6. Chin Med J (Engl). 2009. PMID: 19236801

3

[Dose option of haemophilia prophylaxis in children].

Tang L, Wu RH. Tang L, et al. Among authors: wu rh. Zhonghua Er Ke Za Zhi. 2012 Jan;50(1):70-2. Zhonghua Er Ke Za Zhi. 2012. PMID: 22456080 Review. Chinese. No abstract available.

4

[Clinical analysis of diagnosis, treatment and bleeding pattern of 129 moderate and severe preschool hemophiliacs].

He WW, Wu RH, Wu XY. He WW, et al. Among authors: wu xy, wu rh. Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):420-2. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22781806 Chinese. No abstract available.

5

Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China.

Wu R, Zhang J, Luke KH, Wu X, Burke T, Tang L, Poon MC, Li X, Zhou M, Sun J, Hang M, Blanchette V, Young NL. Wu R, et al. Health Qual Life Outcomes. 2012 Sep 15;10:112. doi: 10.1186/1477-7525-10-112. Health Qual Life Outcomes. 2012. PMID: 22978454 Free PMC article.

6

[Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study].

Wu RH, Wu XY, Zhang NN, Zhao L, Zhang JS, Zhen YZ, Peng Y. Wu RH, et al. Among authors: wu xy. Zhonghua Xue Ye Xue Za Zhi. 2013 Jul;34(7):632-4. doi: 10.3760/cma.j.issn.0253-2727.2013.07.018. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23906463 Chinese. No abstract available.

7

[A cross-sectional survey of coagulation factor VIII inhibitor in children with hemophilia A].

Wei Q, Li G, Tang L, Chen Z, Zhen Y, Wu X, Zhang N, Zhang J, Yu G, Wu R. Wei Q, et al. Zhonghua Er Ke Za Zhi. 2014 Feb;52(2):99-102. Zhonghua Er Ke Za Zhi. 2014. PMID: 24739719 Chinese.

8

[Individualized prophylaxis for hemophilia children based on pharmacokinetics application].

Li P, Wu R. Li P, et al. Zhonghua Xue Ye Xue Za Zhi. 2014 Sep;35(9):869-72. doi: 10.3760/cma.j.issn.0253-2727.2014.09.022. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 25246265 Chinese. No abstract available.

9

Foxp3 methylation status in children with primary immune thrombocytopenia.

Chen Z, Guo Z, Ma J, Ma J, Liu F, Wu R. Chen Z, et al. Hum Immunol. 2014 Nov;75(11):1115-9. doi: 10.1016/j.humimm.2014.09.018. Epub 2014 Oct 7. Hum Immunol. 2014. PMID: 25305033

10

[Relationship between platelet specific antibodies and the onset, clinical manifestation, treatment and prognosis of ITP].

Ma JY, Chen ZP, Wu RH. Ma JY, et al. Among authors: wu rh. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Dec;22(6):1771-4. doi: 10.7534/j.issn.1009-2137.2014.06.051. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25543514 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters